BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months
REPL upcoming catalysts
Replimune, Inc.: 0 upcoming industry Phase 2/3 trial readout(s) in the next 90 days (0 Phase 3), 0 upcoming FDA decision event(s), and in the last 12 months 1 readout(s) and 3 FDA event(s). Subscribe to REPL (.ics).
Drugs: nivolumab
Upcoming FDA decision events
| Date | Event | Status | Company | Drug | Source |
|---|---|---|---|---|---|
| No upcoming PDUFA date or AdCom found. | |||||
Upcoming trial readouts
| Readout | Phase | Sponsor | Trial | Conditions | Status | Enrollment |
|---|---|---|---|---|---|---|
| No trials in this window. | ||||||
FDA decision events, last 12 months
| Date | Event | Status | Company | Drug | Source |
|---|---|---|---|---|---|
| 2026-07-30 | FDA AdCom | held | Replimune, Inc. REPL | AdCom 2026-07-30: Cellular, Tissue, and Gene Therapies Advisory Committee - BLA 125827 | |
| 2026-07-30 | FDA AdCom | held | Replimune, Inc. REPL | AdCom 2026-07-30: Cellular, Tissue, and Gene Therapies Advisory Committee - BLA 125827 | |
| 2026-04-10 | Complete response letter | complete response | Replimune, Inc. REPL | CRL 2026-04-10: Replimune, Inc. BL 125827 |
Trial readouts, last 12 months
| Readout | Phase | Sponsor | Trial | Conditions | Status | Enrollment |
|---|---|---|---|---|---|---|
| 2026-03-01 est. | P2 | Replimune, Inc. REPL | NCT05743270 Study of RP3 in Combination With Nivolumab and Other Therapy in Patients With Locoregionally Advanced or Recurrent SCCHN | Squamous Cell Carcinoma of Head and Neck; Locally Advanced Head and Neck Squamous Cell Carcinoma; Re | withdrawn |
Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line
results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are
company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA
(openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score.
Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP
readout_calendar / fda_decisions. Not investment advice.